Biomarkers Elevated in Patients With Immune Checkpoint Inhibitor-Induced Myocarditis
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Immune checkpoint inhibitor (ICI) myocarditis is associated with changes in noncardiac biomarkers, with elevated creatine phosphokinase (CPK) associated with myocarditis development and all-cause mortality, …
Learn MoreDAAs Less Likely for Hep C Patients With Alcohol Use Disorder
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — For patients with hepatitis C virus (HCV), those with current alcohol use disorder (AUD) or a history of AUD are less likely to receive direct-acting antiviral (DAA) treatment, according to a study published…
Learn MorePennsylvania Man Found Guilty of Massive Fraud Involving Bogus Dog Cancer ‘Cures’
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — A Pennsylvania man who persuaded desperate pet owners that he could help cure their dogs’ cancer was convicted by a federal jury of wire fraud and interstate shipment of misbranded animal drugs.Jonathan Nyce…
Learn MoreNew Insight Into How Dry Eyes Can Weaken Corneas
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Researchers studying dry eye disease in mice have found that the condition can alter how the cornea heals itself. They have also identified potential treatments.“We have drugs, but they only work well in abo…
Learn MorePCP-Specialist Cotraining Improves Patient Experiences
TUESDAY, Jan. 3, 2023 (HealthDay News) — Primary care physician (PCP)-specialist cotraining yields changes in specialist care that improve patient experiences, according to a study published online Jan. 3 in JAMA Internal Medicine.In a quasi-experime…
Learn MorePCP-Specialist Cotraining Improves Patient Experiences
TUESDAY, Jan. 3, 2023 (HealthDay News) — Primary care physician (PCP)-specialist cotraining yields changes in specialist care that improve patient experiences, according to a study published online Jan. 3 in JAMA Internal Medicine.In a quasi-experime…
Learn MoreNo Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
TUESDAY, Jan. 3, 2023 (HealthDay News) — Patients with a history of multisystem inflammatory syndrome in children (MIS-C) do not have an increased risk for serious adverse events after COVID-19 vaccination, according to a study published online Jan. …
Learn MoreNo Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
TUESDAY, Jan. 3, 2023 (HealthDay News) — Patients with a history of multisystem inflammatory syndrome in children (MIS-C) do not have an increased risk for serious adverse events after COVID-19 vaccination, according to a study published online Jan. …
Learn MoreDrug Approved to Help Young Patients Battle a Rare Cancer
TUESDAY, Jan. 3, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved the immunotherapy drug Tecentriq (atezolizumab) for use in patients with unresectable or metastatic alveolar soft part sarcoma (ASPS). The approval was grante…
Learn MoreEE. UU. podría enfrentarse a un aumento en el número de adolescentes con diabetes
VIERNES, 30 de diciembre de 2022 (HealthDay News) — Estados Unidos podría experimentar un inmenso aumento en la diabetes entre los jóvenes en las próximas décadas, encuentra un nuevo estudio de modelado.Hasta 220,000 personas menores de 20 años podrí…
Learn More